We sought the binding targets of the thioaptamers, and identified vimentin, a normally intracellular protein that is specifically expressed on the surface of cells under hyperphosphorylative conditions, as a possible cell surface marker of pathological hyperphosphorylation found in AD. The gene discussed is VIM; the disease is Alzheimer disease.